Cooley LLP > San Francisco, United States > Firm Profile
Cooley LLP Offices
101 CALIFORNIA STREET
5TH FLOOR
SAN FRANCISCO, CA 94111-5800
CALIFORNIA
United States
Cooley LLP > The Legal 500 Rankings
Finance > Capital markets: equity offerings
Fielding a team of ‘incredibly experienced’ attorneys, Cooley LLP routinely advises issuers and managers on all aspects of equity offerings, predominantly focusing on high-profile IPOs and direct listings. The practice has extensive expertise across the biotech, biopharma, and healthcare industries, consistently acting on behalf of private and public companies alongside investment banks. Based out of San Diego, co-lead Charlie Kim is an expert in equity and debt issuances, primarily in the tech and consumer sectors, while in San Francisco, co-head David Peinsipp has expertise in follow-on and 144A offerings. From New York, Div Gupta is knowledgeable in IPOs on shares of common stock, and in Palo Alto, Eric Jensen specializes in capital markets and other corporate transactions, and Jon Avina assists tech companies with securities and governance proceedings. With the team also being well versed in proxy contests and acquisitions, Eric Jensen is a standout in New York, and West Coast’s John-Paul Motley is also highlighted as key.Practice head(s):
Charlie Kim; David Peinsipp
Other key lawyers:
Div Gupta; Eric Jensen; Jon Avina; Eric Blanchard; John-Paul Motley; Christina Roupas; Marc Recht; Richard Segal; Kristin VanderPas; Jean Park; Denny Won; Peter Byrne; Milson Yu; Logan Tiari; Courtney Thorne; Darah Protas; Jonie Kondracki
Testimonials
‘Just an incredibly experienced team for IPO. An ability to understand clients’ business which is exceptional that allows greater chance of IIPO success. Exceptional relationship with SEC.’
‘Div & Ryan are fully dedicated to the company & always available. Their associates are high quality minimizing the risk of errors or lost time.’
‘High motivation and commitment to client standards. Hustles with the best of them and want to deliver the best of the best, but also know how to have fun.’
‘David Peinsipp knows all that you need to know about the law, but brings a fun energy that is rarely seen from many lawyers. Rachel Profitt is best known for her unique ability to connect with clients at a personal levee.’
‘Very active across company and underwriter roles for private and public financings. Also, the team has significant experience in M&A transactions across the biopharma space. The firm size allows them to appropriately cover multiple demands with flexibility and expertise.’
‘Working with Div Gupta, Rich Segal and Darah Protas, one can expect a high-level of professionalism and significant expertise. All three are consistently available to address matters in a timely manner, often anticipating needs before they arise.’
Work highlights
- Advised Rubrik on its upsized $752 million IPO of 23,500,000 shares of Class A common stock at a public offering price of $32 per share. This was the largest software IPO since 2021.
- Advised Tempus AI on its $410 million IPO of 11,100,000 shares of Class A common stock at a public offering price of $37 per share.
- Advised Life360 on its $178.5 million IPO of 6,612,500 shares of common stock at a public offering price of $27 per share.
Healthcare > Life sciences Tier 1
Cooley LLP is a leader across life sciences and healthcare transactions, with significant work in research, licensing and collaboration agreements, M&A, financing, and IPOs. The practice also works on IP strategic counseling and litigation, with San Diego’s Chad Shear leading the firm’s efforts on the latter in 2024. The firm has also led cross-border M&A, demonstrating its ability to work collaboratively across its global offices. The team is headed by Reston-based Christian Plaza and Boston’s Marc Recht, both vastly experienced in public and private transactions, including M&A, securities, and strategic partnerships and collaborations. Showcasing the firm’s strength in supporting partnering transactions, Palo Alto’s Lila Hope led the firm’s representation of SystImmune on the license and collaboration agreement with Bristol Myers Squibb, with a potential value of $8.4bn. Another key member of the team is Ken Krisko, based in Reston, who advises on a range of commercial and corporate finance matters. James Schneider returned to the Boston office in 2024, focusing on emerging companies and venture capital in the life science market. Kate Hillier departed the team in April 2025.Practice head(s):
Christian Plaza, Marc Recht
Other key lawyers:
Chad Shear; Lila Hope; Ken Krisko; James Schneider; Charity Williams; Carlos Ramirez
Key clients
Acadia Pharmaceuticals
Alto Neuroscience
Arsenal Biosciences
Autolus
Beam Therapeutics
Bicycle Therapeutics
Cellares
Eagle Pharmaceuticals
Illumina
Jazz Pharmaceuticals
MapLight Therapeutics
Neurocrine
Poseida Therapeutics
Structure Therapeutics
SystImmune
Tectonic Therapeutic
Tenaya Therapeutics
Y-mAbs Therapeutics
Work highlights
- Advised SystImmune, a clinical-stage biopharmaceutical company, on its exclusive $8.4 billion license and collaboration agreement with Bristol Myers Squibb for SystImmune’s BL-B01D1.
- Advised Arsenal Biosciences (ArsenalBio), a clinical-stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid tumors, on the close of its oversubscribed $325 million Series C financing round.
- Advised Longboard Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, on its $2.6 billion sale to Lundbeck.
M&A/corporate and commercial > Venture capital and emerging companies Tier 1
Cooley LLP is a first port of call for start-ups and emerging companies looking for transactional support. The practice handles a considerable number of venture capital financings annually, where it is equally active on behalf of both investors and companies, while it also advises on IPOs, M&A, and corporate governance matters. A trio of high-profile dealmakers head up the emerging companies and venture capital group: Peter Werner , who recently advised Founders Fund as a co-lead investor in Anduril Industries’ $1.5bn Series F funding round, co-steers the practice from San Francisco together with Matthew Bartus, while Sacha Ross co-directs the group from New York. The bench also includes Palo Alto-based Mark Tanoury, whose four decades of experience ensures he is sought after by emerging companies and venture capital investors for support on strategic matters. Recently promoted to firm CEO, San Francisco-based Rachel Proffitt is a go-to specialist for corporate and securities-related issues, where she enjoys close relationships with public and private companies and investors. Adam Dinow, who heads the New York corporate practice, and Derek Colla, who is a founder of the Miami office, are also highly regarded. Palo Alto-based Sale Kwon is a talented next-generation partner.Practice head(s):
Peter Werner; Matthew Bartus; Sacha Ross
Other key lawyers:
Mark Tanoury; Rachel Proffitt; Adam Dinow; Derek Colla; Sale Kwon; Craig Jacoby; David Young; Eric Jensen; Michael Lincoln; Laurie Bauer; Stephane Levy; Tara Capsuto; Kate Ambrose; Jacob Hanna; Rachel Burns
Testimonials
‘The firm has broad resources to support the practice, including individual practice support but also specialists who can be tapped for specific needs without having to go to another firm for such specialist support.’
‘The team is composed of dedicated team members who are very responsive and creative, including Craig Jacoby, Tara Capsuto, Kate Ambrose, Jacob Hanna and Rachel Burns.’
‘Top strength is their ability to flex up or down depending on the magnitude of the deal or issue at hand. They handle tiny start-ups to massive M&A and I think they do a good job all the way across the spectrum. Their Cooley GO database is helpful too.’
Key clients
Align Ventures
Andreessen Horowitz
Arsenal Biosciences
Augment Computing
Cribl
Harvey
DailyPay, Inc.
Founders Fund
MSD Growth Fund
NGM Biopharmaceuticals
Porsche Automobil Holding SE
QED Investors
Second Front Systems
Slingshot AI
Thrive Capital
Zepto
Work highlights
- Advised Founders Fund as a co-lead investor in Anduril Industries’ $1.5bn Series F funding round.
- Advised India-based Zepto on its $665m Series F financing round and $340m Series G financing round.
- Advised BigID on its $60m Series E funding round.
Media, technology and telecoms > Cyber law (including data privacy and data protection) Tier 1
Advising global tech and software companies, Cooley LLP offers both general compliance advice as well as incident response support for data breaches, credential stuffing attacks and ransomware attacks. The firm is experienced in cyber-related litigation, including class actions, at the state, federal and international levels. It is also knowledgeable of data and privacy issues surrounding generative AI. Splitting his time between Washington DC and San Francisco, Travis LeBlanc is an expert in regulatory enforcement investigations and compliance for cyber and privacy regulations. Matthew Brown, who is based in San Francisco, is a seasoned defense litigator and advisor in government investigations. The Colorado-based David Navetta specialises in data breaches and corporate transactions, especially within the tech and healthcare industries. Divided between Chicago and New York, Tiana Demas supports clients in FTC regulatory enforcements and cybersecurity program assistance. DC-based Michael Egan provides cybersecurity preparedness and response support and has further expertise in cross-borders data flows. Los Angeles-based Teresa Michaud joined the team from Baker McKenzie in February 2024, whilst Kristen Mathews joined from Morrison Foerster in September 2024. Ben Hur joined the firm in 2025 from Willkie Farr & Gallagher LLP.Practice head(s):
Travis LeBlanc
Other key lawyers:
Key clients
Chegg.com
DraftKings Inc.
loanDepot.com, LLC
Sonder Holdings Inc.
Sorenson Communications, LLC
NVIDIA Corporation
Meta
OpenAI
Roblox Corporation
Work highlights
Media, technology and telecoms > Technology transactions Tier 1
Cooley LLP is active at the intersection of tech, business, and intellectual property, combining expertise in commercial transactions with a deep understanding of IP law. Based in Palo Alto, TJ Graham , chair of the tech transactions practice, is renowned for his expertise in high-tech, AI, and digital media deals, advising industry giants on transformative transactions such as Rubrik’s $752m IPO and Zillow’s $400m acquisition of Follow Up Boss. Tracy Rubin, an expert in complex IP transactions, has guided clients on major deals across industries like AI, semiconductors, and digital media, including Carmot Therapeutics’ $2.76bn uisition by Roche. Recently promoted to partner, Caitlin Courtney is highly regarded for her work on strategic licensing, M&A, and commercial deals, including a $125m acquisition, a $1.8bn sale, and a $140m acquisition with a $100m debt facility.Practice head(s):
TJ Graham
Other key lawyers:
Key clients
Rubrik
Zillow
Carmot Therapeutics
Arctic Wolf
Uber Technologies
SiTime Corp
Canary Technologies
Absolute Software
Telegraph
Definitive healthcare
Modo.us
PlayOne Up
Solana Labs
CTIA
Relata Fusion
Work highlights
- Advised Rubrik, the Zero Trust Data Security Company delivering data security and operational resilience for enterprises, on its $752 million initial public offering.
- Advised Arctic Wolf, a leading cybersecurity company that provides security monitoring to detect and respond to cyber threats, including corporate and commercial guidance around the Company’s use of, and public statements concerning its use of, artificial intelligence technologies.
- Advised Battery Ventures, a global, technology-focused investment firm, and PageUp Group, a human resources and talent software company, on the sale of PageUp to EQT Group.
Dispute resolution > Securities litigation: defense Tier 2
Drawing upon an ‘extremely deep bench of talented attorneys’ who have a ‘strong understanding’ of the technology and life sciences sectors, in particular, Cooley LLP is a very popular choice for companies in those domains facing securities class action cases. The team continues to regularly secure victories in pre-trial motions often before discovery, including for a global biotech company when the appellate court recently affirmed a prior lower court decision to dismiss a case on the basis that the plaintiffs failed to adequately plead a false or misleading statement. Palo Alto-based team head Patrick Gibbs was pivotal to this success and is regularly at the forefront of the highest-profile matters handled by the practice, including its ongoing representation of core firmwide client NVIDIA, which recently saw an important ruling handed down by the Supreme Court regarding the pleading standard for scienter. New York-based Sarah Lightdale was also involved in the aforementioned matter and is a key member of the team that includes San Diego-based Koji Fukumura, who is highly skilled at representing life sciences companies, in particular, accused of securities fraud.Practice head(s):
Patrick Gibbs
Other key lawyers:
Luke Cadigan; John Dwyer; Shannon Eagan; Koji Fukumura; Sarah Lightdale; Aric Wu; Peter Adams; Ryan Blair
Testimonials
‘The team has a strong understanding of the industry with top notch legal minds.’
‘The firm has an extremely deep bench of talented attorneys.’
‘Unique (in my experience) combination of understanding of practical business implications of transactions/disputes and legal issues involved. Confident and incredibly accurate in their assessments and advice; unafraid to provide specific and educated predictions. They are the best litigation team I have ever worked with.’
‘I consider Cooley to be a first-tier global litigation firm suitable for bet-the-company type disputes.’
Key clients
American Infrastructure MLP Fund, L.P. (AIM)
Aurinia Pharmaceuticals
Beyond
BioMarin Pharmaceutical
Cantor Fitzgerald
Dutch Bros
Fibrogen
Illumina
Immunovant
IonQ
Mind Medicine (MindMed)
Molecular Partners AG
NVIDIA
Qualcomm
Special Litigation Committee of the Board of Directors of GoDaddy
Talphera
Tandem Diabetes Care
Work highlights
- Defending NVIDIA in a long-running investor class action arising from a $25bn loss in NVIDIA’s market capitalization over a three-month period in late 2018. The case, which was argued before US Supreme Court in November 2024, is poised to resolve two circuit court splits about the allegations necessary to plead falsity and scienter under the heightened standards of the PSLRA.
- Secured a complete victory for online retailer Beyond (formerly known as Overstock.com) when the Tenth Circuit affirmed the lower court’s dismissal of all claims in a securities class action alleging the defendants made false and misleading statements related to financial guidance, and that they engaged in a scheme to manipulate the company’s share price by declaring an unregistered digital dividend, which ultimately led to a short squeeze of the company’s shares.
- Secured a complete victory for BioMarin Pharmaceutical, a global biotechnology company with a focus on rare-disease therapies, when the Ninth Circuit affirmed the lower court’s dismissal of a securities class action alleging the company made false and misleading statements relating to the safety of a gene therapy in a phase 1/2 clinical trial.
Finance > Financial services regulation
Finance > Fintech Tier 2
Intellectual property > Patents: litigation (full coverage) Tier 2
Cooley LLP demonstrates an impressive strength in patent litigation at all stages of operation and across both the life sciences and technology industries. The practice is engaged by market-leading clients, including Meta, Uber, Sight Sciences and Vifor to navigate high-stakes and business-critical matters. Speaking to the team’s wide-ranging expertise, the team successfully defended and sought damages for Sight Sciences in a patent infringement jury trial. The department is chaired by Steve Smith, in Washington DC; Smith is a leading advisor to leading technology companies in competitor cases across the full array of litigation venues. Also in Washinton DC is Sanya Sukduang, a leading advisor for patent disputes to clients in the pharmaceutical, biotechnology and medical device industries. In Palo Alto, Heidi Keefe is a first-chair litigator for technology patent cases, with particular success at the Patent Trial and Appeal Board (PTAB). In San Diego, Chad Shear focuses on high-stakes pharmaceutical patent disputes. Additionally, Reuben Chen in Palo Alto provides additional expertise in medical device and biotechnology patent litigation.Practice head(s):
Steve Smith
Other key lawyers:
Heidi Keefe; Sanya Sukduang; Chad Shear; Reuben Chen
Key clients
Liquidia Technologies, Inc.
Vifor (International) AG
Meta Platforms, Inc.
Science Applications International Corporation
VideaHealth, Inc.
Sight Sciences, Inc.
Zipline International Inc.
Samsung Bioepis Co. Ltd.
Niantic, Inc.
Uber Technologies
CoolIT Systems, Inc.
Absolute Software Inc.
Work highlights
- Represented Sight Sciences, a growth-stage medical device company solving underlying causes of the world’s most prevalent eye diseases. At trial in 2024, the jury found that the plaintiff’s sale of their infringing product caused Sight Sciences to lose sales of its OMNI Surgical System device and awarded our client lost profits damages of $5.5 million and royalty damages of $28.5 million – totalling $34 million.
- Represented CoolIT Systems – a leader in advanced liquid cooling technology for data centers, servers and desktops – in a long-running competitor suit filed by Asetek involving computer liquid cooling technologies in which both sides are asserting patents. Cooley secured a summary judgment victory involving 11 patents across the district court and the PTAB which was then affirmed at the Federal Circuit.
- Defending Niantic, the maker of the Pokémon Go mobile game in a hotly contested augmented reality patent case brought by plaintiff NantWorks, a conglomerate founded by a Los Angeles billionaire. Successfully knocked out the three remaining patents in the ongoing patent infringement suit in the Northern District of California.
Intellectual property > Trademarks: litigation Tier 2
Demonstrating notable capabilities in the tech and life sciences sectors, Cooley LLP is comprised of a solid bench of practitioners who are capable of assisting with high-stakes trademark litigation. The team is a strong choice for start-ups through to global scale clients. The practice is helmed by Washington DC based Brendan Hughes, who covers a full array of trademark disputes, with experience operating before the Second and Sixth Circuit Court of Appeals. In New York, JP Oleksiuk leverages his comprehensive trademark, copyright and advertising law knowledge to assist a plethora of global brands, while in Los Angeles, Bobby Ghajar has a varied practice that encompasses complex trademark and copyright issues, and he is routinely entrusted by sizeable brands and industry leaders.Practice head(s):
Brendan Hughes
Other key lawyers:
Key clients
Google LLC
Meta Platforms
City and County of San Francisco
KKW Beauty, Kimsaprincess, and Kim Kardashian
VideaHealth, Inc.
Automated Pet Care Products, LLC d/b/a Whisker
Origin Materials
Newmark Group (BGC Partners)
Emerson Radio
Patch Technologies
Hailey Rhode Bieber, Rhodedeodato HRBeauty
Spin Master
Work highlights
- Represented the City of San Francisco and Port of San Francisco in a trademark infringement dispute with the City of Oakland and Port of Oakland over the naming of the international airport located in Oakland, and recent name change from Metropolitan Oakland International Airport to San Francisco Bay Oakland International Airport.
- Represented Google in a trademark infringement case brought by Lance Benedict, a professional musician, who had informed Google, that an unnamed “online stalker and convicted felon” published two doctored photos of Benedict on the website.
- Represented Hailey Rhode Bieber, and her companies HRBeauty and Rhodedeodato in a product-line saving victory from allegations of trademark infringement and unfair competition under the federal Lanham Act and New York state law filed by Rhode-NYC.
International trade and national security > CFIUS Tier 2
Cooley LLP, known for its strength in assisting emerging tech and life sciences companies, has been building its CFIUS practice to have the capacity to negotiate National Security Agreements, in line with a marked increase in CFIUS enforcement action. The CFIUS team, in line with the firm’s wider practice areas, regularly supports emerging technology companies in their CFIUS matters and has notable specialisms in complex sectors such as space technology, artificial intelligence, and cyber security. Washington D.C.-based Christopher Kimball established and co-leads the team. Kimball has focussed on developing the team's national security mitigation practice. Kevin King co-leads alongside Kimball, and his client base consists of tech start-ups, established public and private companies, and venture capital firms. Other key lawyers include Dillon Martinson, who has been integral to the firm's ability to prepare submissions, conduct interactions with CFIUS and obtain regulatory approval.Practice head(s):
Christopher Kimball; Kevin King
Other key lawyers:
Work highlights
Media, technology and telecoms > Telecoms and broadcast: regulatory Tier 2
Cooley LLP’s team is based in Washington DC and is well-placed to represent satellite, broadcast and telecoms clients before the FCC. The team is headed up by Robert McDowell who harnesses experience in such FCC work. Travis LeBlanc specializes in crisis management, internal investigations, national security matters and complex litigation, while J.G. Harrington offers advice on the regulations affecting transactions, compliance and bankruptcies, as well as on the development of new products and services. Jason Rademacher routinely represents broadcast, cable, telecoms, tech and new media companies before the FCC and Henry Wendel has a particular focus on transformative transactions and critical advocacy issues. Christy Burrow and Belen Crisp are also standout members of the team. Team changes include the retirement of Michael Basile and the September 2024 arrival of Tony Lin.Practice head(s):
Robert McDowell
Other key lawyers:
Key clients
Gray Television
Echostar
Hughes
Axiom Space
TWN Communications
Iridium Communications
Midcontinent Communications
oneNav
Varda Space
Public Broadcasting Service (PBS)
CBS and FOX Affiliates Boards
Work highlights
- Representing the client in obtaining authorization for granting an extension of the FCC’s authority to conduct auctions for spectrum licenses and in litigation in Washington state courts.
- Representing Iridium Communications in its acquisition of Satelles.
- Advising Gray Television in broadcast transactions and obtaining a first-of-its-kind waiver from the FCC to permit a station sale to occur.
Real estate > Land use/zoning Tier 2
Cooley LLP advises the likes of Vantage Data Centers, Brookfield Properties, and BXP, Inc. on a host of land use and zoning issues, including special exemptions, permits, approvals, zoning, and rezoning. Following Colleen Gillis‘s departure, Reston’s Mark Looney has taken the reins as sole departmental leader – he has considerable experience acquiring the necessary approvals for retail, industrial, mixed-use, and community projects. The team is supported by associate Amanda Williams who helps clients with development applications for data center and fiber optic conduit facility projects. Looney and Williams continue to represent the publicly traded company, Pulte Home Company, as it develops the active adult community, Montebello Farm. Despite controversy and opposition, the team managed to secure rezoning allowing the much-needed housing development.Practice head(s):
Mark Looney
Other key lawyers:
Work highlights
- Representing BXP, a public REIT, on development applications to expand the existing Reston Next development adjacent to the Reston Town Center Metrorail station.
- Representing Compass Datacenters, LLC, one of Inc. Magazine’s 5,000 fastest-growing companies, in connection with zoning approvals for data center projects in Northern Virginia.
Dispute resolution > Corporate investigations and white-collar criminal defense
Cooley LLP specializes in domestic and cross-border investigations, defending clients in a range of white-collar matters, and representing clients against enforcement actions from authorities such as the DOJ, SEC, FTC and CFTC. The firm has deep experience representing the financial sector and handling matters like cybersecurity, FCPA violations, tax fraud, FCA, financial fraud and export controls. Andrew Goldstein, head of the white-collar defense group, leads high-stakes litigations and internal investigations, focusing on FCPA and corruption cases. Russell Capone in Boston brings expertise in white-collar crime, cybercrime, and FCPA violations. John Hemann in San Fransico represents clients in civil trials involving fraud, trade secrets and cybercrimes. The firm also added Rebekah Donaleski, Susanne Sachsman Grooms and John Bostic in 2024, enhancing its white-collar practice.Practice head(s):
Andrew Goldstein
Other key lawyers:
Russel Capone; John Hemann; Rebekah Donaleski; Susanne Sachsman Grooms; John Bostic
Testimonials
‘I have worked with Cooley’s Corporate investigations and white-collar criminal defense practice for the past 4-5 years. They have a deep bench of attorneys with significant and relevant government experience, including former federal prosecutors and SEC staff. They bring a practical and efficient approach to addressing and resolving the matters they assist with and are very good at establishing credibility and a cooperative working relationship with government regulators. They do a very good job of ensuring that their client serving teams are well-balanced from a gender diversity perspective.’
‘This practice is a business first/focused organization that takes the time to listen to its client to fully understand what its needs are. That unfortunately, is innovative in law!’
‘Bekah Donaleski–detail oriented,legally sharp, great communicator, a true advocate.’
‘Cooley has a long roster of former government all-stars who have handled significant cases throughout the country.’
‘Team includes extremely experienced former government practitioners who are smart, thorough, and strong advocates from their clients.’
‘Attention to detail, very strategic and thoughtful, multi-dimensional in approach.’
‘Strong team of former AUSAs across multiple US offices led by very capable Andrew Goldstein’
‘Work mostly with Andrew Goldstein – extremely collaborative, smart, strategic, practical. Strong advocate for his clients. Digs into the details and anticipates problems before they arise.’
Key clients
Abnormal Security
Chegg
Horizon Therapeutics
Indiana University
Rubrik
Work highlights
- Represented Horizon Therapeutics, a specialty biopharmaceutical company, against an attempt by six US states and the US Federal Trade Commission (FTC) attempt to block its $27.8 billion acquisition by Amgen.
- Advised Indiana University on a highly sensitive independent after-action review after receiving significant national press attention and criticism for its actions during recent encampment protests – which were the longest-running nationwide – regarding the war in Gaza.
- Representing security platform Rubrik, which went public in April 2024, in a bet-the-company fraud and antitrust investigation by DOJ, as well as in a parallel internal investigation.
- Represented FTX’s former director of engineering in investigations by the US Attorney’s Office for the SDNY, the SEC, the CFTC and the New York Attorney General’s Office in one of the highest-profile criminal and civil investigations in decades. The Cooley team succeeded in ensuring our client did not receive any prison time.
- Representing a former New Hampshire state senator, in proceedings before the New Hampshire Lottery Commission and two ongoing criminal investigations related to the use of PPP funds.
Dispute resolution > General commercial disputes Tier 3
Regularly called upon by tech and life sciences companies, Cooley LLP represents clients in state, federal and international courts and before various arbitral forums and administrative bodies. The team draws on the firm’s international network to advise on the full range of commercial disputes, from antitrust, consumer protection and IP disputes to contractual, securities and fraud litigation. San Diego-based Michael Attanasio is litigation department chair and Ian Shapiro is head of the New York office. Mazda Antia leads the Southern California business litigation department, while Beatriz Mejia is Northern California head of business litigation practice. Luke Cadigan is head of business litigation for the east coast and head of the Boston office. Also in Boston, Adam Gershenson leads the issues and appeals practice, and Michael Sheetz is a go to for major tech and life sciences companies. David Mills in Washington DC excels in trial and appellate work and government investigations, with expertise in antitrust, whistleblower and class action litigation. Ben Hur and Simona Agnolucci have joined the team from Willkie Farr & Gallagher LLP.Practice head(s):
Michael Attanasio; Mazda Antia; Shannon Eagan; Beatriz Mejia; Ian Shapiro; Luke Cadigan
Other key lawyers:
Adam Gershenson; Michael Sheetz; David Mills; Michael Klisch; Whitty Somvichian; Michael McMahon
Key clients
Chegg
Chicago Title
Molina Healthcare of California
The Pac-12 Conference
Sony Electronics
Pie Insurance
University of Southern California (USC)
OpenAI
Vector Flow
Dotdash Meredith (f/k/a Meredith Corporation)
Inovio Pharmaceuticals, Inc.
IQVIA
Former Republican Governors—California Gov. Arnold Schwarzenegger, Massachusetts Gov. William F. Weld and New Jersey Gov. Christine Todd Whitman
Clubessential, LLC/ClubReady, LLC
Meno Holdings
SeatGeek
Work highlights
- Representing Chegg in multiple litigation matters, including the successful defense of a putative class action asserting a number of claims regarding alleged data breaches.
- Representing appellant in successfully petitioning the California Supreme Court to review her case and achieving a sweeping victory on the merits, which ensures essential whistleblower protections for more than 110,000 charities across California.
- Representing SeatGeek in defense of a putative consumer class action that was filed in the Southern District of New York concerning SeatGeek’s changes to its refund policy in response to the COVID-19 pandemic.
Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco) Tier 3
Cooley LLP’s product safety team is a truly full-service practice, with expertise spanning pre-market reviews, risk assessments, product recalls, government investigations, and post-recall class actions. The firm advises leading consumer, manufacturing, and technology brands on regulatory mandates and innovative products, including new developments and software such as AR/VR devices and consumer electronics. Amongst other significant matters, Cooley currently represents leading manufacturer SunSetter in federal litigation over delayed CPSC reporting of defective powered awnings, involving a $16m penalty and significant reputational risk. Led by Matt Howsare , former US Consumer Product Safety Commission chief of staff, the firm’s leaders are able to leverage deep regulatory experience to counsel high-profile clients on product safety, recalls, regulatory compliance, and multidistrict litigation. Howsare chairs the firm’s North American product safety practice, advising major clients on CPSC civil penalties, compliance programs, and regulatory advocacy. Elliot Kaye, newly joined in 2024 and former chair of the CPSC, offers clients strategic counsel on complex regulatory challenges, crisis management, and compliance issues for executives and boards. Both Howsare and Kaye operate from the firm’s Washington DC office.Practice head(s):
Matt Howsare
Other key lawyers:
Key clients
SunSetter Products LP
Work highlights
- Representing SunSetter in Consumer Product Safety Act litigation filed by the U.S. Department of Justice in a federal district court in the District of Massachusetts.
Finance > Capital markets: debt offerings
Cooley LLP’s capital markets practice continues to build a strong reputation for advising issuers on investment-grade and convertible bond offerings, adding to its established ECM expertise. The group also has some major underwriter clients. With a strong presence in California, the team is noted particularly for its work in the tech, consumer, healthcare, and life sciences spaces, among others; their recent highlights include advising cloud-based data storage company Snowflake Inc., on its 0% $2.3bn inaugural convertible notes offering. With considerable experience handling offerings in the tech and life sciences sectors, Gian-Michele a Marca in San Francisco leads the team. Jason Savich, also in San Francisco, is active in the healthcare and tech sectors and has major issuer clients. Ellie Seber in Los Angeles has a varied practice that covers Rule 144A and convertible senior notes offerings.Practice head(s):
Gian-Michele a Marca
Other key lawyers:
Key clients
Oppenheimer & Co.
Piper Sandler
Snowflake
Uber Technologies
Jazz Pharmaceuticals
Bitdeer Technologies Group
Core Scientific
Air Lease Corporation
Alarm.com
Snap
Jefferies
Cardlytics
Goldman Sachs
Tandem Diabetes Care
Avid Bioservices
Immunocore
NVIDIA Corporation
Unity Software
Xos
Ionis
Work highlights
- Advised Snowflake on its $2.3 billion convertible notes offering comprising $1.15 billion aggregate principal amount of 0% convertible notes due 2027 and $1.15 billion aggregate principal amount of 0% convertible senior notes due 2029.
- Advised Uber in its offering of $1.25 billion aggregate principal amount of 4.300% senior notes due 2030, $1.5 billion aggregate principal amount of 4.800% senior notes due 2034, and $1.25 billion aggregate principal amount of 5.350% senior notes due 2054.
- Advised Snap on its Rule 144A offering of $750 million aggregate principal amount of 0.50% convertible senior notes due 2030, which includes the full exercise of the initial purchasers’ option to purchase an additional $100 million aggregate principal amount of notes.
Finance > Capital markets: global offerings
Cooley LLP‘s broad ECM expertise spans IPOs, follow-on offerings, and ADS offerings, with the group standing out particularly when it comes to IPOs by European issuers. With a strong presence in the key capital markets hubs of New York, Chicago, Boston, and California, the group is well placed to advise clients in the tech, e-commerce, and healthcare/life sciences sectors in particular. Charlie Kim in San Diego is especially strong when it comes to biotech and life sciences IPOs. He chairs the group alongside David Peinsipp in San Francisco, whose varied practice spans IPOs, follow-on offerings, and 144A offerings, among other matters. Div Gupta in New York boasts a blue-chip client roster that includes major healthcare and life sciences companies as well as leading investment banks; he regularly handles IPOs, follow-on offerings, and ADS offerings. Palo Alto’s Eric Jensen is noted for advising high-growth tech, consumer, and life sciences companies as well as investment banks. Boston-based Marc Recht has a strong track record working for European-based issuers in the life sciences space.Practice head(s):
Charlie Kim; David Peinsipp
Other key lawyers:
Testimonials
‘I have been extremely impressed with the entire Cooley team. Unlike most other firms, the attorneys we work with are full life cycle, meaning they are experts in both private company and public company transactions. So, it is the same team who can represent us in any transaction, and who can seemlessly integrate other partners into workstreams without us losing a primary point of contact.’
Key clients
Life360
Silence Therapeutics
Ambrx Biopharma
Autolus Therapeutics
Bicycle Therapeutics
Evercore Group
Exscientia
Valneva
UroGen Pharma
Goldman Sachs & Co.
Cantor Fitzgerald & Co.
Immunocore
J.P. Morgan Securities
Jefferies
Leerink Partners
Legend Biotech
Molecular Partners
Morgan Stanley & Co.
Oculis Holding
Structure Therapeutics
Work highlights
- Advised Life360 on its $178.5 million IPO of 6,612,500 shares of common stock at a public offering price of $27 per share.
- Advised Enlitic on its AU$21 million IPO of 25,366,165 CHESS Depositary Interests (CDIs) over shares of common stock at an issue price of AU$0.83 per CDI.
- Advised Structure Therapeutics on its upsized approximately $547.4 million S-1 follow-on offering of 10,427,017 ADSs, each representing three ordinary shares, at a public offering price of $52.50 per ADS, which included the exercise in full of the underwriters’ option to purchase an additional 1,360,045 ADSs in the offering.
Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings) Tier 3
Cooley LLP frequently works with clients on patent portfolio creation and management and related transactions, due diligence, and financings across a range of sectors. The practice is headed up by Boston-based life sciences and health specialist Matthew Pavao, who is experienced in assisting with global patent acquisition. At the same office, Heidi Elracher offers strategic advice on various high-value cases, while Washington DC-based Chris Holly is noted for his expertise in due diligence. On the West Coast, Mika Reiner Mayer‘s workload includes advising life sciences companies and their investors on the due diligence aspects of patent matters, while Madhuri Roy is also a key name to note in Palo Alto. Former team lead Ivor Elfiri left the New York office in August 2024 for an in-house role.Practice head(s):
Matthew Pavao
Other key lawyers:
Heidi Elracher; Chris Holly; Mika Reiner Mayer; Jonathan Cousin; Joanna Hubberts; Madhuri Roy
Key clients
Versanis Bio
AusperBio
Star Therapeutics
Longitude Capital
Endogenex, Inc.
Alpine Bio
Provivi
AgroSpheres
Pivot Bio
Alto Neurosciences, Inc.
Insmed, Inc.
Jazz Pharmaceuticals, Inc.
Element Biosciences
Bruker Nano Group
Poseida Therapeutics, Inc.
Moderna TX
Degron Therapeutics
MOMA Therapeutics
Clasp Therapeutics
Work highlights
- Representing Moderna TX in developing its global IP strategies to protect and facilitate commercialization of Moderna’s mRNA medicines for use in emerging fields beyond the COVID-19 vaccines.
- Representing Bruker Nano Group in the development of a worldwide patent portfolio generally relating to accessible and top-quality precision medicine and transitional research products.
- Represented Endogenex, Inc. as primary IP counsel since being introduced to the company by leading IP due diligence on behalf of investors for the company’s Series A financing.
Intellectual property > Trade secrets (litigation and non-contentious matters) Tier 3
Cooley LLP‘s regular workload includes representing clients in the range of high-value trade secret theft matters, including those that impact the completion of significant transactions. The practice is jointly headed up by Washington DC-based Stephen Smith, noted for his trial experience, alongside Boston-based Adam Gershenson, who has a strong track record of handling cases before the Supreme Court, and Michael Sheetz, who boasts a specialty in tech and life sciences work. Gershenson's noteworthy highlights include representing Pie Insurance on the first appellate ruling to address what constitutes the ‘reasonable measures’ that must be taken to protect a trade secret per the DTSA 2016. Heidi Keefe in Palo Alto is noted for her standout tech expertise.Practice head(s):
Stephen Smith; Adam Gershenson; Michael Sheetz
Other key lawyers:
Key clients
Liquidia Technologies, Inc.
Group14 Technologies, Inc.
EOFlow Co., Ltd.
Pie Insurance
Wayfair
AnySignal
Mango Technologies (ClickUp)
Lunan Pharmaceuticals
Yext
Mitchell Finer
Zipline International Inc.
Vector Flow, Inc.
Abnormal Security Corporation
ClubReady, LLC
Work highlights
- Representing EOFlow, a South Korean MedTech company, in a high-stakes dispute involving allegations of trade secret theft, patent infringement, trade dress infringement, and unfair competition.
- Defending Pie Insurance in a $300m trade secret dispute.
- Representing Yext in a complex civil lawsuit filed by competitor SOCi, Inc., alleging trade secret misappropriation, breach of contract, civil conspiracy, and tortious interference with contract.
Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing) Tier 3
Steering Cooley LLP’s non-contentious trademark practice from Washington DC is Brendan Hughes, who fields a dynamic registration and maintenance based practice for a range of noteworthy clients. The team more broadly is reputed for its considerable skillset that encompasses global portfolio management, filings and registration work. New York-based JP Oleksiuk is prominent across the fields of trademark, copyright and advertising law, and in Los Angeles, Bobby Ghajar is regularly engaged by sizeable tech, beauty and financial services clients for an extensive variety of trademark, copyright and right of publicity issues.Practice head(s):
Brendan Hughes
Other key lawyers:
Key clients
Upwork Global
Midjourney
Charlotte’s Web
Human Rights Campaign
Coinbase
Sweetgreen, Inc.
Content Square SaS
Necessaire
Bluetooth SIG
COMPASS Pathways
ECI Software Solutions
ServiceNow
Alexandria Real Estate Equities
The Motley Fool
Work highlights
- Cleared hundreds of marks for Google across portfolios, including many of Google’s most sensitive and challenging clearance projects.
- Handled trademark clearance, counseling, prosecution, and enforcement work for Coinbase.
- Handled worldwide trademark portfolio for Bluetooth SIG, the source of the ubiquitous BLUETOOTH wireless technology incorporated into consumer products sold throughout the US and abroad.
Labor and employment > Employee benefits, executive compensation and retirement plans: transactional Tier 3
Cooley LLP is widely recognised for its expertise in executive compensation and employee benefits, advising companies at every stage of their lifecycle. The firm plays a critical role in high-stakes M&A, IPOs, SPAC transactions, and other corporate transitions, ensuring that compensation structures align with strategic business objectives. Led by Barbara Mirza in Los Angeles and a team of top-tier attorneys, including Alessandra Murata in Palo Alto, the practice is known for its ability to navigate complex compensation matters across industries, particularly in technology, life sciences, and artificial intelligence. With a strong presence in key innovation hubs, the firm combines deep industry knowledge with a pragmatic, business-focused approach, positioning itself as a go-to advisor for high-growth companies and market-leading public corporations.Practice head(s):
Barbara Mirza
Other key lawyers:
Blake Martell; Nyron J. Persaud; Austin Holt; Alessandra Murata
Key clients
Rubrik
Gracell Biotechnologies
RayzeBio
ProfoundBio
Everbridge
Carmot Therapeutics
TempusAI
PetIQ
Alto Neuroscience
Snowflake
Avid Bioservices
Longboard Pharmaceuticals
Work highlights
- Advised Rubrik, the first cybersecurity vendor to successfully complete an IPO in over two years, a Zero Trust Data Security Company delivering data security and operational resilience for enterprises, priced at $752 million.
- Advised AuditBoard, a leading connected risk platform transforming audit, risk, compliance, and environmental, social and governance (ESG) management, on the benefits aspects of its agreement to be acquired for more than $3 billion by Hg.
- Advised Amolyt Pharma, a global clinical-stage biopharmaceutical company based in Lyon, France, which specializes in developing therapeutic peptides for rare endocrine and related diseases, on the compensation and benefits aspects of its acquisition by AstraZeneca for up to $1.05 billion in cash.
M&A/corporate and commercial > Shareholder activism Tier 3
Cooley LLP‘s shareholder activism practice is an established presence for clients in the life sciences and pharmaceutical industries, advising established and next-generation public companies on challenges faced by activist investors, including poison pills, proxy contests, board nominations and unsolicited takeover offers. Bill Roegge manages shareholders and reacting to activist campaigns for clients in the contexts of large cross-border corporate transactions and ventures, specializing in proxy contest defense. Also in New York, Kevin Cooper excels in activist campaign preparation all while working on high-profile M&A deals, and San Francisco’s Jamie Leigh, who heads the team, advises boards and committees on strategic matters.Practice head(s):
Jamie Leigh
Other key lawyers:
Transport > Aviation and air travel: litigation and regulation Tier 3
Cooley LLP is well regarded for its ability to handle domestic and cross-jurisdictional accident litigation and airport disputes, acting for airlines, corporations, and municipal authorities. The firm excels at handling ‘bet the company’ cases involving multiple litigants. For example, San Diego-based department head William O’Connor coordinated the firm’s representation of Texatron in a fleetwide dispute involving 700 aircraft owners in 48 states. O’Connor has built a sterling reputation as a litigator, experienced at handling, state, federal and multijurisdictional cases. Out of Washington DC, Parker Erkmann manages the regulatory arm of the practice group, utilizing his experience built in the antitrust division of the Department of Justice. His federal training aids his work with the FAA and the DOT, which helps his airline clients in merger transactions, licensing, and DOT certification.Practice head(s):
William O’Connor
Other key lawyers:
Parker Erkmann
Key clients
Aevex Holdings, LLC
Air Tariff Publishing Company
Air Wisconsin Airlines
Bell Helicopter Textron
Hawaiian Airlines
JetBlue Airways Corporation
MD Helicopters
Textron
Town of East Hampton
Work highlights
- Retained by Textron and Textron Aviation to represent it in a fleet-wide dispute regarding the Cessna TTx aircraft
- Retained by Ikhana to handle a dispute with Viking Aircraft involving Ikhana’s portfolio of FAA-approved supplemental type certificates,
- Defending MD Helicopters in multiple litigations stemming from helicopter crashes.
Dispute resolution > International arbitration Tier 4
Cooley LLP‘s arbitration practice is recognised for its impressive cross-border capabilities, and representing leading technology and life sciences clients on highly sensitive, complex matters. The team represents Google, Zoom, and OpenAI, notably representing Google in a high-value ICDR arbitration against a Hong Kong based advertising company. Leadership of the team is based in New York, consisting of Marc Suskin, Rachel Thorn, and Teresa Michaud. Thorn has vast experience repersenting clients in commercial and investment treaty arbitrations, while Suskin represents leading tech clients in matters spanning digital advertising, artificial intelligence, and cryptocurrency, and notably acts on mass arbitrations. Michaud joined the team from Baker McKenzie LLP in February 2024.Practice head(s):
Marc Suskin; Rachel Thorn; Teresa Michaud
Testimonials
‘Cooley has a leading technology related arbitration team which has close client relationships with Google and other silicon valley heavy weights. Their work, especially in disputes with mainland Chinese companies, has been a foundational aspect of their overall arbitration practice. They are very creative, especially in dealing with interim measures and other preservation tactics against complex adverse parties. Sophisticated.’
‘Marc Suskin is outstanding – calm but aggressive and highly experienced dealing with the complex legal issues arising from common Chinese corporate structures. He is very sophisticated.’
‘Rachel Thorn is exceptional – she’s creative and grasps the finest detail.’
Key clients
Google (please note that Google is a Cooley client is publishable. All further details, including about work, are highly confidential unless otherwise noted)
Coinbase Inc. (Please note that Coinbase is a Cooley client is publishable. All further details, including about work, are highly confidential)
Zoom Video Communications. (Please note that Zoom is a Cooley client is publishable. All further details, including about work, are highly confidential)
NVIDIA (Please note that NVIDIA is a Cooley client is publishable. All further details, including about work, are highly confidential)
Ouster, Inc.
Chegg (please note that Chegg is a Cooley client is publishable. All further details, including about work, are highly confidential unless otherwise noted)
OpenAI (please note that OpenAI is a Cooley client is publishable. All further details, including about work, are highly confidential unless otherwise noted)
Invitae
Jazz Pharmaceuticals
Genomatica, Inc.
United Talent Agency, LLC (please note that UTA is a Cooley client is publishable. All further details, including about work, are highly confidential unless otherwise noted)
Structure Therapeutics, Inc.
Work highlights
- Cooley represents Google Asia in a dispute against a Hong Kong-based advertising company (ICDR Rules).
- Cooley represents Odyssey Marine Exploration in an arbitration brought under Chapter 11 of the North American Free Trade Agreement against Mexico (UNCITRAL Rules).
- Cooley represents Structure Therapeutics and its CEO in a motion to compel arbitration brought under Article III of the New York Convention, or alternatively Section 4 of the Federal Arbitration Act, currently pending in federal court in the Northern District of California.
International trade and national security > Customs, export controls and economic sanctions Tier 4
Cooley LLP's export control and sanctions practice has continued its impressive growth under the leadership of Kevin King and remains a very active player in the technology market. In line with the firm's wider strength in tech-related legal issues, the export controls and sanctions team has been notably active in issues pertaining to semiconductors, AI applications, space technology, and technology-focused venture funds. Annie Froehlich focuses her practice on matters arising under the EAR and ITAR sanctions programs. Shannon MacMichael handles international review matters such as risk assessments and product and technology classifications. Karen Tsai and Sarah Oliai are key members of the team.Practice head(s):
Kevin King; Annie Froehlich
Other key lawyers:
Work highlights
Investment fund formation and management > Private equity funds (including venture capital) Tier 4
Cooley LLP, whose team is predominantly based in California, but offers a nationwide practice reaching the firm’s Boston office, has a practice which is strongly geared towards the field of venture capital fund formation. The team has clients including some of Silicon Valley’s original venture firms, as well as high-growth emerging companies and investing in early-stage funds, but also is involved in fund deals relating to the US, China, and other jurisdictions. Located in Palo Alto, John Dado spearheads the team, with a client base of early-stage venture capital firms and top venture capital firms, and centers his practice around the formation of venture capital or buyout funds. John Clendenin, also in Palo Alto. In San Francisco, Eric Doherty advises some of the group’s largest funds.Practice head(s):
John Dado
Other key lawyers:
John Clendenin; Jimmy Matteucci; Matthew Smith
Key clients
01 Advisors
A*
Acrew Capital
Andreessen Horowitz
Galvanize Climate Solutions
Haun Ventures
Headline
M33 Growth
Refactor Capital
Redpoint
Sentinel Global
Slow Ventures
QED Investors
Venrock
Work highlights
- Represented Andreessen Horowitz (a16z) in the closing of US$7.2 billion for the following new funds, American Dynamism (US$600 million), Applications (US$1 billion), Games (US$600 million), Infrastructure (US$1.25 billion) and Growth (US$3.75 billion).
- Advised Institutional Venture Partners (IVP) on the raise of its US$1.6 billion 18th fund to partner with transformational technology companies and help supercharge their growth.
- Advised Menlo Ventures on its close of US$1.35 billion in new capital.
Labor and employment > Workplace and employment counseling Tier 4
Cooley LLP counsels a diverse range companies on the full spectrum of employment issues, with marked capabilities in the life sciences and tech industries. Based in Palo Alto, Wendy Brenner chairs the group and counsels companies on issues concerning worker classification, employee complaints, workplace investigations and restrictive covenants. In San Francisco, Joshua Mates has extensive experience as a litigator and counselor, handling day-to-day matters such as compliance and diversity initiatives as well as employment issues arising from M&A transactions. Helen Connolley specializes in advising emerging companies on workforce development and is based in Reston.Practice head(s):
Wendy Brenner
Other key lawyers:
Joshuna Mates; Helen Connolley
Key clients
Snowflake
Huntress
University of Chicago
Lacework
Vaxxinity
Lumentum Holdings
Happy Money
Electric Power Research Institute (EPRI)
M&A/corporate and commercial > Corporate governance Tier 4
The growing corporate governance practice at Cooley LLP specializes in assisting boards of established publicly traded corporations and private companies preparing for their IPO. The practice works with high-profile clients such as NVIDIA and Zoom, advising on best board practices, institutional investor voting policies, and SEC compliance. The team is led by San Francisco’s David Peinsipp alongside New York’s Beth Sasfai and Brad Goldberg. Goldberg excels at ensuring clients remain in accordance with securities law and the rules of exchange listings whilst Safsai works with both domestic and international clients with ESG regulations, risk management, and stakeholder management.Practice head(s):
David Peinsipp; Beth Sasfai; Brad Goldberg
Other key lawyers:
Joe Avina; Chadwick Mills; Sarah Sellers; Eric Jensen
Key clients
NVIDIA
Snowflake
Rubrik
Instacart
Zoom
Confluent
Dutch Bros, Inc.
C3.ai
Everbridge
Vivid Seats
ACELYRIN
Jazz Pharmaceuticals
Geron Corporation
Cerus Corporation
Eagle Pharmaceuticals
Rigetti Computing
Y-mAbs Therapeutics
Work highlights
- Representing Rubrik in ongoing corporate governance matters, advising on the technical and tactical aspects of corporate governance, best practices for boards and committees, securities laws, stock exchange corporate governance standards, proxy advisory firm and institutional investor voting policies, bylaws, and other governance documents and policies, shareholder engagement strategies, shareholder proposals, board and committee meeting attendance, SEC disclosures, and ESG and sustainability matters.
- Representing Instacart in ongoing corporate governance matters, advising on the technical and tactical aspects of corporate governance, best practices for boards and committees, securities laws, stock exchange corporate governance standards, proxy advisory firm and institutional investor voting policies, bylaws, and other governance documents and policies, shareholder engagement strategies, shareholder proposals, board and committee meeting attendance, SEC disclosures, and ESG and sustainability matters.
- Represented Jazz Pharmaceuticals for over a decade and continues to represent the company in ongoing corporate governance and corporate securities work, advising on the technical and tactical aspects of corporate governance best practices for boards and committees, securities laws, stock exchange corporate governance standards, proxy advisory firm and institutional investor voting policies, bylaws and other governance documents and policies, shareholder engagement strategies, shareholder proposals, and SEC and disclosure.
Real estate Tier 4
The real estate team at Cooley LLP consistently plays a key role in major mixed-use, transit-oriented development projects. The practice has a sophisticated knowledge of development projects, regarding office leasing, hospitality, and retail properties. Furthermore, the team evidences an exceptional knowledge of data center transactions, with experience in the acquisition, planning, zoning, construction, and financing of complex data centers. The team is led by John Lavoie, based out of Reston; he focuses his practice on the acquisition and disposition of real estate, including office, industrial, retail, and technology-driven asset classes. Supporting from the Reston office is Michelle Garcia Schulman, who has experience in assisting companies with all aspects of data center transactions, and representing both landlords and tenants involved in major lease transactions.Practice head(s):
John Lavoie
Other key lawyers:
Key clients
Hoffman & Associates – West Falls
Hoffman & Associates – The Wharf
Coresite
Starwood Capital
Digital Realty
Parsons Business Park LLC
DataBank
Tysons Corner Office+
Acuity Brands
Washington English Center
Work highlights
- Representing Hoffman & Associates in its office leasing at The Wharf.
- Representing Starwood Capital in Fairfax County, Virginia on a large Data Center lease/purchase transaction in the US.
- Representing Digital Realty on multiple data center sites in Loudoun County and Prince William County.
Antitrust > Civil litigation/class actions: defense Tier 5
Work highlights
Antitrust > Merger control Tier 5
Clients in the life sciences and tech sectors regularly seek out the Cooley LLP antitrust and competition team, based in Washington DC and working closely with colleagues across Chicago, San Diego, New York, London, and Brussels. Ethan Glass heads the practice, which was bolstered in October 2024 by the addition of Jeremy Morrison from Jones Day. Morrison takes clients from premerger planning to post-closing investigations, with experience across the energy, transportation, and retail sectors. For matters at the intersection of antitrust and intellectual property law, Howard Morse is recommended. Kathy O’Neill has departed the firm.Practice head(s):
Ethan Glass
Other key lawyers:
Megan Browdie; Jeremy Morrison; Howard Morse
Key clients
JetBlue
Carmot Therapeutics
Steward Health
VectivBio Holdings
Jackpocket
Transact Campus
Sazerac
AuditBoard
Everbridge
RayzeBio
Work highlights
- Advised JetBlue Airways Corporation in the US DOJ’s lawsuit and in a separate private challenge to block the merger of JetBlue and Spirit.
- Advised Jackpocket, a first-in-class third-party lottery courier app in the US, on its agreement to be acquired by DraftKings.
- Advised Steward Health in the sales of a physician group (“Stewardship Health”) in connection with its pending bankruptcy, ultimately leading to a successful disposition of the assets.
Finance > Commercial lending Tier 5
Well-regarded for its life science and technology financing capabilities, Cooley LLP is headed by San Francisco-based Mischi Marca. Marca is notably experienced in debt financing transactions, credit facilities, and acquisition financing, he is also a key port of call for banks and private equity firms on secured and unsecured credit facilities. Operating out of Washington DC, Michael Tollini is highly proficient in syndicated bank lending and royalty-based financing, while New York-based Patrick Flanagan is experienced in both domestic and international leveraged finance transactions. Located in San Francisco, Jason Savich is often engaged in an array of structured financing matters, while Los Angeles-based Elliie Seber is informed in derivatives transactions. Seber’s caseloads also includes convertible bond offerings and capital markets transactions.Practice head(s):
Mischi a Marca
Other key lawyers:
Key clients
Uber Technologies, Inc
Sazerac Company Inc
BioMarin Pharmaceutical Inc
Aviation Capital Group LLC
Grindr, Inc
Rubrik, Inc
Versata Enterprises, Inc
Battery Ventures
Cellares Corporation
Calliditas Therapeutics AB
Olema Pharmaceuticals, Inc
Accel Partners
TriSalus Life Sciences
Cytokinetics, Inc
Work highlights
- Advised Uber on a $5 billion investment-grade revolving credit facility.
- Advised Sazerac Company on a $3.1 million credit facility from Wells Fargo Bank.
- Advised BioMarin Pharmaceuticals on a $600 million credit facility provided by Citibank.
M&A/corporate and commercial > M&A: large deals ($1bn+) Tier 5
The rapidly growing M&A department at Cooley LLP demonstrates expertise in both buy- and sell-side deals and regularly advises leading companies on business expansion opportunities and strategic exits. Integrating a cross-practice approach by liaising with the firm’s corporate and regulatory teams, the group is co-led by San Diego-based Barbara Borden, and San Francisco-based Jamie Leigh, who advises tech and financial companies on takeover and activist defense engagements, and proxy contests. Well-known for representing tech startups, San Diego duo Rowook Park and Rama Padmanabhan are skilled in public and private M&A, and life sciences sector deals, respectively. In New York, Kevin Cooper advises emerging companies on complex corporate transactions, while San Francisco’s Ben Beerle covers joint venture deals.Practice head(s):
Barbara Borden; Jamie Leigh
Other key lawyers:
Key clients
Everbridge
Jackpocket
Amolyt Pharma
Transact Campus
PetIQ
Accel
AuditBoard
Carmot Therapeutics
ProfoundBio
RayzeBio
Snowflake
Horizon Therapeutics
Gracell Biotechnologies
Grindr
Uber
Work highlights
- Advised RayzeBio on its sale to Bristol Myers Squibb for $62.50 per share in cash, for a total equity value of approximately $4.1bn, or $3.6bn net of estimated cash acquired.
- Advised Carmot Therapeutics on its sale to Roche at a purchase price of $2.7bn upfront and the potential for $400m in milestone payments.
- Advised AuditBoard on its approximately $3bn sale to HG.
Finance > Restructuring (including bankruptcy): corporate Tier 6
Cooley LLP has established itself as a genuine force in restructurings and bankruptcies, particularly in the technology, healthcare and life sciences sectors. The firm is best known for its representation of debtors, including distressed emerging companies or businesses that have been through a de-SPAC process, though it also frequently acts for creditors’ committees in large-scale matters. It has continued to act for clients in a series of major Chapter 11 cases and out-of-court restructurings, and is further recognised for distressed M&A. Cullen Drescher Speckhart is chair of the business restructuring practice. Chicago partner Eric Walker is also recognised for restructurings and bankruptcies in the healthcare sector. Michael Klein is a key figure in New York, while Olya Antle impresses at senior associate level. Named individuals are based in Washington DC unless stated otherwise.Practice head(s):
Cullen Drescher Speckhart
Other key lawyers:
Eric Walker; Michael Klein; Olya Antle; Lauren Reichart
Testimonials
‘Cooley is highly commercial in the negotiation of a deal, but fully prepared and ready to litigate when it needs to act in the best interests of its client.’
‘Olya Antle is someone you want on your deal. She is brilliant and highly effective. Olya is calm under pressure, has strong writing skills and is an excellent advocate in court.’
‘They have made a name for themselves in representing tort claimants in mass tort bankruptcies. They also benefit from having a lot of emerging growth clients which need workout/restructuring advice. They are a leader in de-SPAC bankruptcies, for example.’
‘Cullen Speckhart is a powerhouse lawyer and a great person. I am so impressed with how she has grown the stature of the group. Olya Antle is an up-and-coming global restructuring lawyer. Lauren Reichart is a well-respected up-and-coming restructuring lawyer in NYC.’
‘Cullen Speckhart is a hard working, smart, commercial attorney with a great demeanor. She leads a talented team. They have broad skillsets, from company side to creditor committee, to boards.’
‘Cullen Speckhart is so valuable in the industry. She can go toe-to-toe with any adversary.’
Key clients
PhaseBio Pharmaceuticals
DeCurtis Holdings
Endo International – Counsel to Official Committee of Opioid Creditors
Whittaker Clark & Daniels – Counsel to Official Committee of Unsecured Creditors
Quanergy Systems
Gamida Cell
Lucira Health
LTL Management – Counsel to Official Committee of Mesothelioma Claimants
Enjoy Technology
Fisker Owners Association (FOA)
Yardi Systems
ZOLL Medical
Lifespace Communities
AMASS Brands
Work highlights
- Advised Gamida Cell and its wholly owned subsidiary, Gamida Cell, on the company’s global restructuring, which ensured Gamida’s life-saving therapeutic, Omisirge, could stay in production.
- Advised PhaseBio in its Chapter 11 proceedings.
- Represented the Opioid claimants of Endo International Official Committee in the Endo International bankruptcy proceedings.
Tax > US taxes: non-contentious Tier 6
Cooley LLP ’s tax practices represent Uber Technologies, Snowflake, and several other leading firms in the financial services, technology, and life sciences industries. Todd Gluth spearheads the practice in San Diego, which frequently advises clients on the tax implications of large-scale M&A deals, financial restructurings, and joint ventures. Bluth is a technology specialist, involved in some of the industry’s biggest deals including advising Auditboard on their $3bn acquisition by Hg. Other key names in the practice include Eileen Marshall in Washington DC, Rick Jantz, and Alexander Lee who are both based in Los Angeles.Practice head(s):
Todd Gluth
Other key lawyers:
Eileen Marshal; Rick Jantz; Alexander Lee
Key clients
Alarm.com
Andreessen Horowitz
AuditBoard
Brii Biosciences
CallTower
Cerberus Capital Management
ChrysCapital
Delphix
Hootsuite
PlayAGS
ProfoundBio
Radionetics Oncology
RayzeBio
Snowflake
Structure Therapeutics
SystImmune
Uber Technologies
Yardi Systems
Work highlights
- Advised AuditBoard, a leading connected risk platform transforming audit, risk, compliance, and environmental, social and governance (ESG) management, on its agreement to be acquired for more than $3 billion by Hg, an experienced and leading global investor in compliance, risk and accounting software over the last 20 years.
- Advised Cerberus Capital Management, a premier alternative investment firm, on its strategic investment of up to $315.5 million in Eos Energy, a leading provider of safe, scalable, efficient, and sustainable zinc-based, long-duration energy storage systems.
- Advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its definitive agreement to be acquired for $1.8 billion in an all-cash transaction by Genmab, a dual-listed, international biotechnology company that creates and develops differentiated antibody therapeutics to fight against cancer and other serious diseases.
Tax > Financial products
Worldwide > Capital markets Tier 1
Worldwide > Data protection Tier 1
Worldwide > Private equity Tier 1
Cooley LLP > Firm Profile
Cooley’s lawyers solve legal issues for entrepreneurs, investors, financial institutions and established public and private companies with an emphasis on tech, life sciences and other high-growth industries. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. Cooley maintains an environment of inclusion and is proud to be recognized by Law360 as a “Best Law Firm for Minority Partners.” The firm has 1,200+ lawyers across 17 offices in the US, Asia and Europe.
Main areas of practice
Corporate: Key corporate strengths include capital markets, M&A, emerging and public companies, venture capital, tech transactions and life sciences corporate partnering and licensing. Cooley is continuously ranked as the most active law firm representing issuers and underwriters in IPOs in the life sciences and tech sectors. Cooley’s leadership in this area gives us deep industry-specific experience as corporate counsel to high-growth companies.
Litigation: Key litigation strengths include advertising, antitrust, appellate, arbitration, business restructuring, class actions, employment, insurance, IP litigation, ITC, life sciences and healthcare, patent, privacy and cybersecurity, product liability, regulatory, securities, tax, trademark and white-collar. Cooley’s global trial practice has won verdicts and awards worth billions of dollars and protected clients against competitors, consumers and regulators. The team includes five partners who are ACTL Fellows and 20+ former Assistant US Attorneys and Department of Justice lawyers. Cooley offers experience in 100+ state, federal and international courts, arbitral forums and administrative bodies.
Intellectual property: Cooley has one of the largest full-service IP practices of any law firm in the US that serves as IP counsel to 1,000+ companies across all industry sectors worldwide. Key strengths include IP litigation across all major venues; patent counseling and prosecution; trademark, copyright and advertising; and due diligence, licensing and strategic transactions. Notably, Cooley has one of the largest life sciences and medical device patent teams in the US. In 2020, the firm filed 5,000+ patent applications and 3,000 trademark applications globally for its clients. Cooley has also collectively led 1,000+ investor-side and company-side due diligence reviews in high-value deals and transactions.
Regulatory: Key strengths include antitrust and competition, communications, financial services, government contracts, insurance, healthcare, education, international trade, media and securities. Cooley has significant experience representing clients in investigations and matters involving the SEC, DOJ, FTC, FCC, ITC, DOD, DOE, EPA, NSC, EEOC, Treasury and other federal agencies.
Antitrust and competition: Providing a full range of counseling, litigation, agency representation and arbitration services, Cooley handles all aspects of antitrust/competition law and trade regulation matters for Fortune 500 corporations, as well as growing companies, in virtually every sector.
Capital markets: Cooley is the leading law firm for all US company-side IPOs since 2014 and VC-backed technology and healthcare and life sciences IPOs for the last 15+ years, according to Deal Point Data and IPO Vital Signs
respectively.
Cyber/data/privacy: Cooley’s cyber/data/privacy practice is a global team of lawyers focusing on all aspects of cyber, data protection and privacy. The firm represents clients across all industries, ranging from emerging to Fortune 500 companies, across the full spectrum of privacy and cyber-related issues. Cooley has successfully litigated a wide range of cases involving privacy and data breach issues, including class actions and government enforcement actions.
Emerging companies: Cooley represents 6,000+ private companies across all industries. Over the past decade, Cooley has represented thousands of technology, life sciences and other high-growth businesses with all aspects of their formation and development. The firm is involved in 1,300+ financings annually and is ranked as the #1 law firm representing VC-backed companies going public for the last decade.
Intellectual property litigation: Cooley’s IP litigators win cases across the US and UK in every conceivable forum and manner. They are experienced in all types of IP cases including patent, Section 337 investigations, trademark, trade dress, trade secret, copyright, false advertising, domain name and licensing matters. With nearly 600 IP cases in the last five years, including 500+ patent cases and 950+ trademark and copyright disputes worldwide, Cooley is widely acknowledged as one of the top IP litigation practices in the US.
Life sciences: With almost 1,800+ public and private life science company clients worldwide, Cooley is the leading deal firm across all aspects of corporate and transactional practices, including M&A, IPOs, financings and private equity work. Cooley represents almost 50% of the NASDAQ Biotechnology Index and is widely known as a best-in-class firm for handling corporate partnering and licensing transactions.
M&A: Since 2017, Cooley has handled 1,000+ M&A transactions, with an aggregate value of $375+ bn, making our practice one of the most active in the country, particularly for technology and life sciences companies.
Public companies: Cooley counsels public companies in high-stakes, complex business and litigation matters. Cooley represents 1,500+ public companies, and for 200+, serves as principal corporate governance and securities counsel. The team has extensive experience and familiarity with federal and state securities laws enabling us to be strategic advisors to seasoned and newly public companies.
Securities litigation: Cooley has one of the most active practices for the defense of issuers in shareholder litigation in the US. The firm’s securities litigation clients include a diverse range of businesses and individuals, including startups and Fortune 500 companies.
Fund formation: Cooley has been building funds globally for 60+ years and is counsel to 500+ investment fund organizations. The firm completed 370+ fund closings in 2020, raising over $34 bn in capital commitments. The team advises on every type of fund formation: venture capital, fund of funds, private equity, evergreen, growth equity and other managers at all stages and sizes, from individual angel funds to billion-dollar institutional funds.
Private equity: Cooley’s team has guided leading private equity sponsors in some of the market’s largest and most complex transactions.
Tax: The firm has a market reputation for innovative, tax-efficient structuring of business transactions and effective resolution of significant tax controversies.
Real estate: The team’s diverse capabilities allow us to explore all facets of real estate development and craft the best business-oriented solutions for its clients. Cooley assist owners, operators, developers, lenders, tenants, and institutional investors and advisors with a wide variety of real property and related capital markets transactions as well as litigation.
Technology transactions: The firm’s technology transactions team combines intellectual property and commercial transactions expertise, which enables them to meet the demands of a fast-evolving, increasingly global environment. Many of the firm’s lawyers have “in house” legal or business experience with technology companies; all dealmakers who have an aptitude for, and keen interest in, the technologies that help their clients thrive.
Compensation and benefits: Cooley’s compensation and benefits group addresses its clients’ needs to compensate, reward and protect their employees and other service providers. The firm brings together the ERISA, tax, corporate, labor and securities law skills necessary to deal effectively with the structuring and administration of its clients’ most complex compensation and benefit programs.
Main Contacts
Department | Name | Telephone | |
---|---|---|---|
Corporate (capital markets, M&A, emerging companies, venture capital, tech transactions and life sciences, corporate partnering and licensing) | |||
Litigation (advertising, appellate, antitrust, class actions, employment, ITC, international arbitrations, patent, privacy, regulatory, securities, tax controversy, trademark and white-collar) |
Staff Figures
Number of Partners : 375+ Number of Other Fee-Earners : 1200+ Total Staff : 3,300+Other
Chairman & CEO : Joe Conroy Vice Chair : Michael Lincoln- Finance > Capital markets: equity offerings
- Healthcare > Life sciences
- M&A/corporate and commercial > Venture capital and emerging companies
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Media, technology and telecoms > Technology transactions
Top Tier Firm Rankings
- Dispute resolution > Securities litigation: defense
- Finance > Financial services regulation
- Finance > Fintech
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Trademarks: litigation
- International trade and national security > CFIUS
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Real estate > Land use/zoning
Firm Rankings
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > General commercial disputes
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Capital markets: debt offerings
- Finance > Capital markets: global offerings
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- M&A/corporate and commercial > Shareholder activism
- Transport > Aviation and air travel: litigation and regulation
- Dispute resolution > International arbitration
- International trade and national security > Customs, export controls and economic sanctions
- Investment fund formation and management > Private equity funds (including venture capital)
- Labor and employment > Workplace and employment counseling
- M&A/corporate and commercial > Corporate governance
- Real estate
- Antitrust > Civil litigation/class actions: defense
- Antitrust > Merger control
- Finance > Commercial lending
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Worldwide > Capital markets
- Worldwide > Data protection
- Worldwide > Private equity